28 Results for "

Isoform-selective

" in MedChemExpress (MCE) Product Catalog:
Products (28)

28 Results for "Isoform-selective" in MCE Product Catalog:

5
5 Cited Publications
Cat. No.: HY-119254
CAS No.: 2099142-76-2
Purity:  98.33%
Research Areas:  

Metabolic Disease

BAY-850, a chemical probe, is a potent and isoform selective ATPase family AAA domain-containing protein 2 (ATAD2) inhibitor, with an IC50 of 166 nM .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-134194
CAS No.: 302939-48-6
Purity:  98.18%
Target:  

Cryptochrome

Research Areas:  

Metabolic Disease

KL201 a circadian clock modulator, is a isoform-selective cryptochrome 1 (CRY1) stabilizer. KL201 has no stabilizing effect on CRY2. KL201 lengthens the period of circadian rhythms in cells and tissues .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-D1341
CAS No.: 878019-47-7
Research Areas:  

Cancer

Coumberone is a metabolic fluorogenic probe, and isoform-selective substrate for all AKR1C isoforms. Coumberone can be reduced by all four members of the AKR1C family to its fluorescent alcohol coumberol. Coumberone can be used for the research of AKR1C .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-18540
CAS No.: 1402612-55-8
Target:  

MAGL DAGL

KT109 is a potent and an isoform-selective inhibitor of diacylglycerol lipase-β (DAGLβ) with an IC50 of 42 nM. KT109 has ~60-fold selectivity for DAGLβ over DAGLα. KT109 shows inhibitory activity against PLA2G7 (IC50=1 µM). KT109 shows negligible activity against FAAH, MGLL, ABHD11, and cytosolic phospholipase A2 (cPLA2 or PLA2G4A). KT109 perturbs a lipid network involved in macrophage inflammatory responses and lowers 2-Arachidonoylglycerol (HY-W011051), Arachidonic acid (HY-109590) and eicosanoids in mouse peritoneal macrophages .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-13531
CAS No.: 648449-76-7
Purity:  99.95%
Target:  

PI3K

Research Areas:  

Cancer

AS-604850 is a potent, selective and ATP-competitive PI3Kγ inhibitor with an IC50 value of 0.25 μM and a Ki value of 0.18 μM. AS-604850 shows isoform selective inhibitor of PI3Kγ with over 30-fold selectivity for PI3Kδ and β, and 18-fold selectivity over PI3Kα, respectively .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-108526
CAS No.: 59662-49-6
Purity:  99.70%
Target:  

RAR/RXR Autophagy

Research Areas:  

Others

AC-55649 is a potent, highly isoform-selective agonist of human RARβ2 receptor, with a pEC50 of 6.9.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-128772
CAS No.: 2230144-21-3
Purity:  98.85%
Target:  

Sodium Channel

Research Areas:  

Neurological Disease

XPC-6444 is a highly potent, isoform-selective, and CNS-penetrant NaV1.6 inhibitor (IC50=41 nM for hNaV1.6). XPC-6444 also displays potent block of NaV1.2 (IC50=125 nM). XPC-6444 shows anticonvulsant activity .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P2261
CAS No.: 1542100-77-5
Target:  

PKA

Research Areas:  

Infection

STAD 2 is a potent and selective disruptor of PKA-RII, with a Kd of 6.2 nM. STAD 2 disrupts interactions between PKA and AKAP in an isoform-selective manner. STAD 2 displays antimalarial activity through a PKA-independent mechanism .
loading...
    loading...
Cat. No.: HY-16596
CAS No.: 1276105-89-5
Target:  

PI3K

Research Areas:  

Cancer

CNX-1351 is a potent and isoform-selective targeted covalent PI3Kα inhibitor with IC50 of 6.8 nM.
loading...
    loading...
Cat. No.: HY-153450
CAS No.: 2308504-22-3
Purity:  99.75%
Research Areas:  

Cancer

JBI-589 is a non-covalent PAD4 isoform-selective inhibitor with oral bioavailability. JBI-589 reduces CXCR2 expression and blocks neutrophil chemotaxis. JBI-589 reduces primary tumor and metastases, and enhances the anti-tumor effect of checkpoint inhibitors. JBI-589 can be used in cancer research .
loading...
    loading...
Cat. No.: HY-108532
CAS No.: 870773-76-5
Purity:  99.27%
Target:  

RAR/RXR

Research Areas:  

Cancer

AC-261066 is a potent, orally available and isoform-selective retinoic acid beta2 (RARbeta2) receptor agonist, with a pEC50 of 8.0 .
loading...
    loading...
Cat. No.: HY-137295
CAS No.: 59086-90-7
Purity:  99.96%
Ingenol 3,20-dibenzoate is a potent protein kinase C (PKC) isoform-selective agonist. Ingenol 3,20-dibenzoate induces selective translocation of nPKC-delta, -epsilon, and -theta and PKC-mu from the cytosolic fraction to the particulate fraction and induces morphologically typical apoptosis through de novo synthesis of macromolecules. Ingenol 3,20-dibenzoate increases the IFN-γ production and degranulation by NK cells, especially when NK cells are stimulated by NSCLC cells .
loading...
    loading...
Cat. No.: HY-125838
CAS No.: 2366255-71-0
Purity:  99.90%
Target:  

JNK

Research Areas:  

Neurological Disease

J30-8 is a potent and isoform-selective inhibitor of c-Jun N-terminal kinase 3 (JNK3) with an IC50 of 40 nM, which 2500-fold isoform selectivity against JNK1α1 and JNK2α2. J30-8 exhibits neuroprotective activity in vitro and potential for the treatment of neurodegenerative diseases .
loading...
    loading...
Cat. No.: HY-111509
CAS No.: 1854901-94-2
Target:  

ROR

Research Areas:  

Inflammation/Immunology

TAK-828F is a potent, selective, and orally available retinoic acid receptor-related orphan receptor γt (RORγt) inverse agonist (binding IC50=1.9 nM, reporter gene IC50=6.1 nM). TAK-828F shows excellent RORγt isoforms selectivity (>5000-fold selectivity against human RORα and RORβ) .
loading...
    loading...
Cat. No.: HY-123825
CAS No.: 1432913-36-4
GX-674 is a potent, state-dependent, isoform-selective voltage-gated sodium channel 1.7 (Nav1.7) antagonist with an IC50 of 0.1 nM at -40 mV .
loading...
    loading...
Cat. No.: HY-119254A
Purity:  98.12%
Research Areas:  

Metabolic Disease

trans-BAY-850 is the trans isomer of BAY-850 (HY-119254). BAY-850 is a potent and isoform selective ATPase family AAA domain-containing protein 2 (ATAD2) inhibitor, with an IC50 of 166 nM.
loading...
    loading...
Cat. No.: HY-175865
Target:  

HSP Apoptosis

Research Areas:  

Cancer

HSP70-IN-7 is a nonselective HSP70 inhibitor with Kds of 4.71, 2.16 and 2.93μM against HSP70, GRP75, and GRP78. HSP70-IN-7 exhibits selective toxicity against breast cancer cells, induces cell apoptosis and effectively suppresses the properties of breast cancer stem cells (BCSCs). HSP70-IN-7 can be used for the study of breast cancer .
loading...
    loading...
Cat. No.: HY-175975
CAS No.: 3048204-93-6
Target:  

PROTACs Akt

Research Areas:  

Cancer

PROTAC Akt3 Degrader-1 is a highly efficient and selective PROTAC degrader targeting Akt3. PROTAC Akt3 Degrader-1 shows weak antiproliferative activity in 36 cell lines. PROTAC Akt3 Degrader-1 can be used for the study of Triple-negative breast cancer and melanoma .
loading...
    loading...
Cat. No.: HY-131305
CAS No.: 154675-18-0
Purity:  98.03%
Target:  

PKC Apoptosis

Research Areas:  

Neurological Disease

HBDDE, a derivative of Ellagic acid, is an isoform-selective PKCα and PKCγ inhibitor with IC50s of 43 μM and 50 μM, respectively. HBDDE shows selective for PKCα/PKCγ over PKCδ, PKCβI and PKCβII isozymes. HBDDE induces neuronal apoptosis .
loading...
    loading...
Cat. No.: HY-178956
CAS No.: 2393980-27-1
Target:  

HSP

Research Areas:  

Cancer

KUNB106 is a selective Hsp90β inhibitor with KDs of 91 nM and 38 μM against Hsp90β and Hsp90α. KUNB106 exhibits antiproliferative activity against MDA-MB-231 cells, A549 and SKOV-3 cells. KUNB106 can be used for the study of triple negative breast cancer .
loading...
    loading...